{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:09:29Z","timestamp":1793822969706,"version":"4.6.1"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T00:00:00Z","timestamp":1676505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Neutrophil\/high-density lipoprotein (HDL) ratio (NHR), monocyte\/HDL ratio (MHR), lymphocyte\/HDL ratio (LHR), platelet\/HDL ratio (PHR), systemic immune-inflammation index (SII), system inflammation response index (SIRI), and aggregate index of systemic inflammation (AISI) have been recently investigated as novel inflammatory markers. Herein, the correlation was investigated between these inflammatory biomarkers and peripheral arterial disease (PAD) in type 2 diabetes mellitus (T2DM) patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this retrospective observational study, the hematological parameter data of 216 T2DM patients without PAD (T2DM-WPAD) and 218 T2DM patients with PAD (T2DM-PAD) at Fontaine stages II, III or IV stage had been collected. Differences in NHR, MHR, LHR, PHR, SII, SIRI, and AISI were analyzed, and receiver operating characteristic (ROC) curves were used to analyze the diagnostic potential of these parameters.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The levels of NHR, MHR, PHR, SII, SIRI and AISI in T2DM-PAD patients were significantly higher than in T2DM-WPAD patients (\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.001). They were correlated with disease severity. Further, multifactorial logistic regression analyses showed that higher NHR, MHR, PHR, SII, SIRI, and AISI might be independent risk factors for T2DM-PAD (\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.001). The areas under the curve (AUCs) of the NHR, MHR, PHR, SII, SIRI, and AISI for T2DM-PAD patients was 0.703, 0.685, 0.606, 0.648, 0.711, and 0.670, respectively. The AUC of the NHR and SIRI combined model was 0.733.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The levels of NHR, MHR, PHR, SII, SIRI, and AISI were higher in T2DM-PAD patients, and they were independently linked with its clinical severity. The combination model of NHR and SIRI was most valuable for predicting T2DM \u2013 PAD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2023.1100453","type":"journal-article","created":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T07:14:41Z","timestamp":1676531681000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":132,"title":["Combination model of neutrophil to high-density lipoprotein ratio and system inflammation response index is more valuable for predicting peripheral arterial disease in type 2 diabetic patients: A cross-sectional study"],"prefix":"10.3389","volume":"14","author":[{"given":"Yi","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhuo","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baorui","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruonan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyun","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangyang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,2,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.24.8.1433","article-title":"Peripheral arterial disease in diabetic and nondiabetic patients","volume":"24","author":"Jude","year":"2001","journal-title":"Diabetes Care"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.12.2843","article-title":"Peripheral arterial disease, diabetes, and mortality","volume":"27","author":"Leibson","year":"2004","journal-title":"Diabetes Care"},{"key":"B3","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12933-018-0781-1","article-title":"Lower extremity arterial disease in patients with diabetes: A contemporary narrative review","volume":"17","author":"Nativel","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.2337\/dc20-S001","article-title":"Improving care and promoting health in populations: Standards of medical care in diabetes-2020","volume":"43","year":"2020","journal-title":"Diabetes Care"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.022194","article-title":"Clinical update: Cardiovascular disease in diabetes mellitus: Atherosclerotic cardiovascular disease and heart failure in type 2 diabetes mellitus - mechanisms, management, and clinical considerations","volume":"133","author":"Low Wang","year":"2016","journal-title":"Circulation"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v5.i4.444","article-title":"Type 2 diabetes and cardiovascular disease: Have all risk factors the same strength","volume":"5","author":"Mart\u00edn-Tim\u00f3n","year":"2014","journal-title":"World J Diabetes"},{"key":"B7","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s13054-020-02860-3","article-title":"High-density lipoproteins during sepsis: From bench to bedside","volume":"24","author":"Tanaka","year":"2020","journal-title":"Crit Care"},{"key":"B8","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12944-020-01238-2","article-title":"Neutrophil to high-density lipoprotein ratio has a superior prognostic value in elderly patients with acute myocardial infarction: A comparison study","volume":"19","author":"Huang","year":"2020","journal-title":"Lipids Health Dis"},{"key":"B9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12944-021-01462-4","article-title":"Compared with the monocyte to high-density lipoprotein ratio (MHR) and the neutrophil to lymphocyte ratio (NLR), the neutrophil to high-density lipoprotein ratio (NHR) is more valuable for assessing the inflammatory process in parkinson\u2019s disease","volume":"20","author":"Liu","year":"2021","journal-title":"Lipids Health Dis"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.583320","article-title":"Lymphocyte to high-density lipoprotein ratio but not platelet to lymphocyte ratio effectively predicts metabolic syndrome among subjects from rural China","volume":"8","author":"Yu","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3403","article-title":"The platelet to high density lipoprotein -cholesterol ratio is a valid biomarker of nascent metabolic syndrome","volume":"37","author":"Jialal","year":"2021","journal-title":"Diabetes Metab Res Rev"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1093\/neuros\/nyab354","article-title":"Systemic immune-inflammation index predicts delayed cerebral vasospasm after aneurysmal subarachnoid hemorrhage","volume":"89","author":"Geraghty","year":"2021","journal-title":"Neurosurgery"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.944991","article-title":"Monocyte-to-high-density lipoprotein ratio and systemic inflammation response index are associated with the risk of metabolic disorders and cardiovascular diseases in general rural population","volume":"13","author":"Wang","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2022.2083671","article-title":"Prognostic value of systemic inflammatory response index in patients with acute coronary syndrome undergoing percutaneous coronary intervention","volume":"54","author":"Han","year":"2022","journal-title":"Ann Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s44197-021-00021-5","article-title":"Combined blood indexes of systemic inflammation as a mirror to admission to intensive care unit in COVID-19 patients: A multicentric study","volume":"12","author":"Hamad","year":"2022","journal-title":"J Epidemiol Glob Health"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.727419","article-title":"Prognostic value of leucocyte to high-density lipoprotein-cholesterol ratios in COVID-19 patients and the diabetes subgroup","volume":"12","author":"Wang","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2020.1849739","article-title":"The usefulness of monocyte-to-High density lipoprotein and neutrophil-to-Lymphocyte ratio in diabetic macular edema prediction and early anti-VEGF treatment response","volume":"30","author":"Yalinbas Yeter","year":"2022","journal-title":"Ocul Immunol Inflamm"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.762242","article-title":"Monocyte to high-density lipoprotein cholesterol ratio at the nexus of type 2 diabetes mellitus patients with metabolic-associated fatty liver disease","volume":"12","author":"Jia","year":"2021","journal-title":"Front Physiol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S377465","article-title":"The novel predictive biomarkers for type 2 diabetes mellitus in active pulmonary tuberculosis patients","volume":"15","author":"Yu","year":"2022","journal-title":"Infect Drug Resist"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00191","article-title":"The role of monocyte to high-density lipoprotein cholesterol ratio in prediction of carotid intima-media thickness in patients with type 2 diabetes","volume":"10","author":"Chen","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.935776","article-title":"Monocyte to high-density lipoprotein and apolipoprotein A1 ratios: Novel indicators for metabolic syndrome in Chinese newly diagnosed type 2 diabetes","volume":"13","author":"Wang","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1177\/0003319720965808","article-title":"The Monocyte\/High density lipoprotein cholesterol ratio (MHR) as an indicator of the need for amputation in patients with peripheral artery disease developing critical limb ischemia","volume":"72","author":"Ceyhun","year":"2021","journal-title":"Angiology"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2020.4644","article-title":"Platelet\u2212to\u2212lymphocyte ratio, neutrophil\u2212to\u2212lymphocyte ratio and monocyte\u2212to\u2212HDL cholesterol ratio as markers of peripheral artery disease in elderly patients","volume":"46","author":"Selvaggio","year":"2020","journal-title":"Int J Mol Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202105_25826","article-title":"Neutrophil-to-lymphocyte ratio but not monocyte-to-HDL cholesterol ratio nor platelet-to-lymphocyte ratio correlates with early stages of lower extremity arterial disease: An ultrasonographic study","volume":"25","author":"Santoro","year":"2021","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-S006","article-title":"Glycemic targets: Standards of medical care in diabetes\u20132021","volume":"44","year":"2021","journal-title":"Diabetes Care"},{"key":"B26","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","article-title":"2017 ESC Guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European society for vascular surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: The European stroke organization (ESO)The task force for the diagnosis and treatment of peripheral arterial diseases of the European society of cardiology (ESC) and of the European society for vascular surgery (ESVS)","volume":"39","author":"Aboyans","year":"2018","journal-title":"Eur Heart J"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000471","article-title":"2016 AHA\/ACC guideline on the management of patients with lower extremity peripheral artery disease: A report of the American college of Cardiology\/American heart association task force on clinical practice guidelines","volume":"135","author":"Gerhard-Herman","year":"2017","journal-title":"Circulation"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1055\/s-0034-1393976","article-title":"Overview of classification systems in peripheral artery disease","volume":"31","author":"Hardman","year":"2014","journal-title":"Semin Intervent Radiol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1016\/j.jvs.2006.12.037","article-title":"Inter-society consensus for the management of peripheral arterial disease (TASC II)","author":"Norgren","year":"2007","journal-title":"J Vasc Surg"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.26.12.3333","article-title":"Peripheral arterial disease in people with diabetes","volume":"26","year":"2003","journal-title":"Diabetes Care"},{"key":"B31","doi-asserted-by":"publisher","first-page":"12054","DOI":"10.3390\/ijms231912054","article-title":"Inflammatory and prothrombotic biomarkers, DNA polymorphisms, MicroRNAs and personalized medicine for patients with peripheral arterial disease","volume":"23","author":"Poredo\u0161","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B32","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12933-017-0581-z","article-title":"Serum high mobility group box-1 and osteoprotegerin levels are associated with peripheral arterial disease and critical limb ischemia in type 2 diabetic subjects","volume":"16","author":"Giovannini","year":"2017","journal-title":"Cardiovasc Diabetol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12933-017-0559-x","article-title":"Elevated serum fibroblast growth factor 23 levels as an indicator of lower extremity atherosclerotic disease in Chinese patients with type 2 diabetes mellitus","volume":"16","author":"He","year":"2017","journal-title":"Cardiovasc Diabetol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12933-019-0880-7","article-title":"Association between plasma omentin-1 levels in type 2 diabetic patients and peripheral artery disease","volume":"18","author":"Biscetti","year":"2019","journal-title":"Cardiovasc Diabetol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s12933-020-01171-9","article-title":"Association of serum Cyr61 levels with peripheral arterial disease in subjects with type 2 diabetes","volume":"19","author":"Feng","year":"2020","journal-title":"Cardiovasc Diabetol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12933-019-0805-5","article-title":"Sortilin levels are associated with peripheral arterial disease in type 2 diabetic subjects","volume":"18","author":"Biscetti","year":"2019","journal-title":"Cardiovasc Diabetol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nrcardio.2015.124","article-title":"Dysfunctional HDL and atherosclerotic cardiovascular disease","volume":"13","author":"Rosenson","year":"2016","journal-title":"Nat Rev Cardiol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"E1835","DOI":"10.3390\/ijms21051835","article-title":"The diabetes mellitus-atherosclerosis connection: The role of lipid and glucose metabolism and chronic inflammation","volume":"21","author":"Poznyak","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2012.01.008","article-title":"Monocytes as a diagnostic marker of cardiovascular diseases","volume":"217","author":"Gratchev","year":"2012","journal-title":"Immunobiology"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.12.022","article-title":"Neutrophil counts and initial presentation of 12 cardiovascular diseases: A CALIBER cohort study","volume":"69","author":"Shah","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/s41569-019-0214-1","article-title":"Neutrophil-driven SMC death destabilizes atherosclerotic plaques","volume":"16","author":"Fern\u00e1ndez-Ruiz","year":"2019","journal-title":"Nat Rev Cardiol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20012044","article-title":"A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation","volume":"196","author":"Massberg","year":"2002","journal-title":"J Exp Med"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1172\/JCI27196","article-title":"Platelets in inflammation and atherogenesis","volume":"115","author":"Gawaz","year":"2005","journal-title":"J Clin Invest"},{"key":"B44","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/j.1749-6632.2012.06480.x","article-title":"LDL-cholesterol versus HDL-cholesterol in the atherosclerotic plaque: Inflammatory resolution versus thrombotic chaos","volume":"1254","author":"Badimon","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"B45","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.it.2003.10.013","article-title":"Inflammation: The link between insulin resistance, obesity and diabetes","volume":"25","author":"Dandona","year":"2004","journal-title":"Trends Immunol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s12933-021-01383-7","article-title":"Comparison of various insulin resistance surrogates on prognostic prediction and stratification following percutaneous coronary intervention in patients with and without type 2 diabetes mellitus","volume":"20","author":"Zhao","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2022.2104919","article-title":"Systemic inflammatory response index over neutrophil\u2013lymphocyte ratio and monocyte\u2013lymphocyte ratio: Comparison of prognostic performance in predicting major adverse cardiac events","volume":"54","author":"Mangalesh","year":"","journal-title":"Ann Med"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1100453\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T07:14:44Z","timestamp":1676531684000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1100453\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,16]]},"references-count":47,"alternative-id":["10.3389\/fendo.2023.1100453"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1100453","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,16]]},"article-number":"1100453"}}